with severe arthralgia (5) . Human infections with chikungunya virus are associated with sudden onset of symptoms including headache, fever, rash, and muscle and joint pain (5) . Before the outbreak in the Indian Ocean islands, deaths had not been associated with infections. However, Réunion Island reported >200 deaths during the 2006 chikungunya epidemic (January-April 2006) (6) , and India conservatively estimated 1, 194 CDRs on the Island of Mauritius in March, April, and May 2006 were signifi cantly greater than expected (p<0.01 for all 3 months); this corresponds to 743 excess deaths for these months (Figure) . The chikungunya fever epidemic in Mauritius began ≈1 month before the fi rst month of reported excess deaths; 4,871 cases of chikungunya fever cases were reported in February, 5,084 in March, and 2,305 in April. Rodrigues Island showed a similar trend, with an increase in the number of observed deaths in April, May, and June (p<0.01 for May). The fi rst confi rmed case of chikungunya fever on Rodrigues Island was reported in February, followed by 56 cases in March, 393 in April, and >80 in May (9) .
The increase in CDRs reported for the Republic of Mauritius during the chikungunya epidemic is similar to the fi ndings reported for the neighboring island of Réunion (10) . Excess deaths in Réunion and the Republic of Mauritius coincided with the epidemic curve of the chikungunya fever outbreak, which suggested an association between these 2 factors. No other events that may have negatively affected the health of persons living in the Republic of Mauritius in 2006 were reported. However, because information on cause of death is unavailable, studies are needed to confi rm that the chikungunya fever outbreak contributed to increased CDRs in 2006.
Increasing Resistance in Commensal Escherichia coli, Bolivia and Peru
To the Editor: The global increase of antimicrobial-drug resistance, including resistance to the new and most potent antimicrobial agents, is a major public health concern. In low-resource countries, where bacterial infections are still among the major causes of death, especially for children, it is of particular concern (1).
ANTRES (Towards Controlling Antimicrobial Use and Resistance in Low-income Countries-An Intervention Study in Latin America) is a research project on antimicrobial-drug use and resistance in low-resource countries of Latin America (see www.unifi . it/infdis/antres/default.htm). In 2002, the baseline ANTRES study showed a high rate of fecal carriage of Escherichia coli with acquired resistance to several antimicrobial drugs, especially older drugs (e.g., ampicillin, trimethoprimsulfamethoxazole, tetracycline, streptomycin, and chloramphenicol), in preschool children from 4 urban settings in Bolivia and Peru (2) . We report the results of a second cross-sectional study, conducted in 2005, that evaluated the evolution of antimicrobialdrug resistance in the studied areas.
We studied healthy children 6-72 months of age from each of 4 urban areas: 2 in Bolivia (Camiri, Santa Cruz Department; Villa Montes, Tarija Department) and 2 in Peru (Yurimaguas, Loreto Department; Moyobamba, San Martin Department). The study design, sampling and inclusion criteria, methods, and ethical issues were the same as those of the baseline study (2) . The study was carried out over 4 months (September-December 2005), the same seasonal period as in the previous study. No signifi cant differences in sex ratios were found among children enrolled from the different areas,
